Yesterday's FDA Decision On Generic Restasis...

After FDA's decision on Monday 6/24/2013 Allergan shares dropped to $80!!!

This after FDA's approval of the notion that companies do not need to conduct patient studies to market generic Restasis starting in May 2014.

Layoffs will be coming soon in anticipation of this news just like it happened at Pfizer (50% cuts to the sales force) for years in anticipation of Lipitor going generic in 2011:

http://www.reuters.com/article/2013/...etsNews&rpc=43